Progress on catastrophic health spending in 133 countries: a retrospective observational study A Wagstaff, G Flores, J Hsu, MF Smitz, K Chepynoga, LR Buisman, ... The Lancet Global Health 6 (2), e169-e179, 2018 | 563 | 2018 |
Measuring progress towards universal health coverage: with an application to 24 developing countries A Wagstaff, D Cotlear, PHV Eozenou, LR Buisman Oxford Review of Economic Policy 32 (1), 147-189, 2016 | 115 | 2016 |
Persistent inequalities in child undernutrition: evidence from 80 countries, from 1990 to today C Bredenkamp, LR Buisman, E Van de Poel International Journal of Epidemiology 43 (4), 1328-1335, 2014 | 109 | 2014 |
Financial protection from health spending in the Philippines: policies and progress C Bredenkamp, LR Buisman Health Policy and Planning 31 (7), 919-927, 2016 | 83* | 2016 |
Assessing Latin America’s progress toward achieving universal health coverage A Wagstaff, T Dmytraczenko, G Almeida, L Buisman, ... Health Affairs 34 (10), 1704-1712, 2015 | 82 | 2015 |
Progress on Global Health Goals: Are the Poor Being Left Behind? A Wagstaff, C Bredenkamp, LR Buisman The World Bank Research Observer 29 (2), 137-162, 2014 | 78 | 2014 |
Hospital costs of ischemic stroke and TIA in the Netherlands LR Buisman, SS Tan, PJ Nederkoorn, PJ Koudstaal, WK Redekop Neurology 84 (22), 2208-2215, 2015 | 57* | 2015 |
What explains the fall in child stunting in Sub-Saharan Africa? LR Buisman, E Van de Poel, O O'Donnell, EKA van Doorslaer SSM-Population Health 8, 1-8, 2019 | 56 | 2019 |
THE EARLY BIRD CATCHES THE WORM: EARLY COST-EFFECTIVENESS ANALYSIS OF NEW MEDICAL TESTS. LR Buisman, MP Rutten-van Mölken, D Postmus, JJ Luime, ... International Journal of Technology Assessment in Health Care 32 (1-2), 46-53, 2016 | 50 | 2016 |
Progress toward the health MDGs: are the poor being left behind? A Wagstaff, C Bredenkamp, L Buisman World Bank Policy Research Working Paper, 2014 | 26 | 2014 |
Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost–utility analysis of … PHP de Jong, JM Hazes, LR Buisman, PJ Barendregt, D van Zeben, ... Rheumatology 55 (12), 2138-2147, 2016 | 25 | 2016 |
A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis LR Buisman, JJ Luime, M Oppe, JMW Hazes, MPMH Rutten-van Mölken Arthritis research & therapy 18, 1-12, 2016 | 20 | 2016 |
Measuring Progress towards universal health coverage: with an application to 24 developing countries A Wagstaff, D Cotlear, PHV Eozenou, L Buisman World Bank Policy Research Working Paper, 2015 | 19 | 2015 |
Mongolia-Health equity and financial protection report C Bredenkamp, LR Buisman, LM Prencipe, A Somanathan, T Tsilaajav, ... The World Bank, 2012 | 17 | 2012 |
Who benefits from government health spending and why? A global assessment A Wagstaff, M Bilger, L Buisman, C Bredenkamp A Global Assessment (September 1, 2014). World Bank Policy Research Working …, 2014 | 15 | 2014 |
Cost‐Effectiveness Model for Evaluating New Diagnostic Tests in the Evaluation of Patients With Inflammatory Arthritis at Risk of Having Rheumatoid Arthritis JJ Luime, LR Buisman, M Oppe, JMW Hazes, MPMH Rutten‐van Mölken Arthritis Care & Research 68 (7), 927-935, 2016 | 14 | 2016 |
A cost‐effectiveness model for evaluating new diagnostic tests in the work‐up of patients with inflammatory arthritis at risk of having Rheumatoid Arthritis JJ Luime, LR Buisman, M Oppe, JMW Hazes, MPMH Rutten‐van Mölken Arthritis Care & Research 68 (7), 927-935, 2016 | 14* | 2016 |
Who benefits from government health spending and why A Wagstaff, M Bilger, LR Buisman, C Bredenkamp A global assessment, 2014 | 13 | 2014 |
Inequity in inpatient healthcare utilisation 10 years after Apartheid LR Buisman, P García-Gómez Development Southern Africa 32 (2), 193-208, 2015 | 12 | 2015 |
Progress on catastrophic health spending in 133 countries: a retrospective observational study. Lancet Glob Health. 2018; 6 (2): e169-79 A Wagstaff, G Flores, J Hsu, MF Smitz, K Chepynoga, LR Buisman | 12 | |